Farther Finance Advisors
LUCD icon

Farther Finance Advisors’s Lucid Diagnostics LUCD Stock Holding History

Farther Finance Advisors’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.88K Buy
9,167
+8,926
+3,704% +$8.34K ﹤0.01% 4826
2026
Q2 		$256 Buy
241
+224
+1,318% +$241 ﹤0.01% 5676
2026
Q1 		$20 Buy
+17
New +$22 ﹤0.01% 5652

Other funds holding LUCD

Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
TIA
Traphagen Investment Advisors Oradell, New Jersey $1.46B AUM 14.92% 1-Year Est. Return
Sax Wealth Advisors
Sax Wealth Advisors Parsippany, New Jersey $3.5B AUM 13.73% 1-Year Est. Return
AP
Anchyra Partners Atlanta, Georgia $477M AUM 34.33% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Farther Finance Advisors's LUCD Position: Q3 2026 in Review

Farther Finance Advisors increased its Lucid Diagnostics (LUCD) stake by 3,704% in Q3 2026, buying an estimated $8.34K and bringing the position to 9,167 shares worth $6.88K. The position accounts for ﹤0.01% of the portfolio, ranked #4826.

Farther Finance Advisors first reported a position in LUCD in Q1 2026 and has held it in 3 quarters since. 9 funds tracked by Wall St. Rank hold LUCD as of Q3 2026.

  • Farther Finance Advisors held 9,167 shares of Lucid Diagnostics worth $6.88K as of Q3 2026.
  • Farther Finance Advisors bought 8,926 Lucid Diagnostics shares in Q3 2026, an estimated $8.34K.
  • Lucid Diagnostics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4826 holding.
  • Farther Finance Advisors first reported a position in Lucid Diagnostics in Q1 2026 and has held it in 3 quarters since.
  • 9 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.